about
Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDMRole of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expressionGlucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic β-cellsAblation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo.The transcription factor Pax6 is required for pancreatic β cell identity, glucose-regulated ATP synthesis, and Ca2+ dynamics in adult miceCarbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells.Remote control of glucose homeostasis in vivo using photopharmacology.LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.ChREBP regulates Pdx-1 and other glucose-sensitive genes in pancreatic β-cellsRIP2-mediated LKB1 deletion causes axon degeneration in the spinal cord and hind-limb paralysis.AMP- and stress-activated protein kinases: key regulators of glucose-dependent gene transcription in mammalian cells?Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasisHypothalamic AMP-activated protein kinase regulates glucose production.Imaging glucose-regulated insulin secretion and gene expression in single islet beta-cells: control by AMP-activated protein kinase.Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+ Stores.The AMP-regulated kinase family: enigmatic targets for diabetes therapy.Cell-wide analysis of secretory granule dynamics in three dimensions in living pancreatic beta-cells: evidence against a role for AMPK-dependent phosphorylation of KLC1 at Ser517/Ser520 in glucose-stimulated insulin granule movement.Roles of Ca2+ ions in the control of ChREBP nuclear translocation.Impact of adenoviral transduction with SREBP1c or AMPK on pancreatic islet gene expression profile: analysis with oligonucleotide microarrays.Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and MiceLocal and regional control of calcium dynamics in the pancreatic islet.AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells.AMP-activated protein kinase: a new beta-cell glucose sensor?: Regulation by amino acids and calcium ions.Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion.Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression.Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia.Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation.Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.5'-AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics.MiR-184 expression is regulated by AMPK in pancreatic islets.ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic beta-cells.Expression of COUP-TFII in metabolic tissues during development.Manipulation and Measurement of AMPK Activity in Pancreatic Islets.40th EASD Annual Meeting of the European Association for the Study of DiabetesCorrection: Transcription factor-7-like 2 () gene acts downstream of the kinase to control mTOR signaling, β cell growth, and insulin secretionTranscription factor-7-like 2 () gene acts downstream of the / kinase to control mTOR signaling, β cell growth, and insulin secretionNo change in glucose tolerance and substrate oxidation after a high-carbohydrate, low-fat dietThe 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex
P50
Q24562990-96E4C464-8BEE-46B3-9C11-D767C9BF6981Q24682898-FD48A7AF-2E42-4524-8497-7B135CBD5EEBQ28506748-5FBDDF46-F3FC-4F74-A52A-A17E7B05F7B9Q30618321-A5E80FA5-BCEE-4BD5-96CE-23F840B20C82Q30853901-E004B383-014C-4871-8BCE-D8F262F93058Q33556480-EC6BDDD9-3244-40B2-8B9F-3C859F1E5F85Q33670713-1C9F6A39-5177-4417-9C47-9270385D1D50Q33916529-72FA2C4F-E185-4020-B993-46A127E93CB5Q34339116-B2FE4E8E-0CCD-4CC8-8EE8-5DF3839F247DQ34611758-2C6FD273-4CB5-439D-8DBD-915023AD0485Q34725643-FA4B0C1A-1427-457B-8AEF-ED5C9F744CE5Q35168497-B6B8F162-0966-4DAB-B810-BE883EB2438FQ35757198-DCA78E1E-F153-47DC-952D-015057E39B3DQ35853906-A4A995E8-0DCB-48D7-99D3-714651B8CBBDQ36725795-5674759A-749B-4210-B4BA-D1F6271DF506Q37210623-76BD5A75-E5C7-4A8C-8F71-F2002A7AD2ABQ37674811-1165D746-FD84-48EF-92B3-802EFCF7DF80Q37991980-9EF30F5F-AA20-4292-83F8-278C8D075CDEQ38333910-3783235F-7B39-4E19-903F-D32625B717EDQ38993206-23EC2829-D57C-4AF1-8BC6-72B0B7A2175BQ39280087-4CD30FB3-5C6C-4531-AB09-9E53132D72E9Q39645465-3E6A1DB1-26A3-484C-813F-0A9A8E8ACEE3Q40488463-A4B48D7F-9949-46D7-B363-5368A2B8DA6AQ40590712-2FD873E4-C8BF-4B69-9602-9EC866DF6C6FQ40670353-07788817-F8D0-46EA-80DD-D0A1A5FDC5C5Q42156889-0BB11210-19A4-4251-A19A-076347EE9B28Q42501625-D44CF895-29E0-4D0A-8609-56E60EF00E5DQ42518217-29BA648B-44C8-4660-8F36-24F3FE5CFC90Q42794214-065EB5C5-B4F5-4CA6-8C33-2D56F01CF24CQ43982388-458C7B39-C315-41B7-8986-1B13F6753A47Q44610054-3ACBE418-DE25-4082-9270-41C79B9C3FEDQ47263946-651AB776-4355-4D99-80AE-8861D3F675B2Q51584416-9FFDD805-E27F-4AA7-8DE1-73CBB30CB0AEQ52113671-F3383F64-E687-4993-8617-1BC5E54D738EQ52730397-2ECCFAA9-D007-4E1B-94A1-65C7A500BDD2Q57249806-81C1AC1B-BEBF-479D-B09C-DDDBD1340A6FQ59329162-C2565CE3-DBDB-491C-9024-62DACF6652A6Q63543947-76BFE431-58F4-40AA-B548-662CEE04B58EQ70699388-EF65C42B-156F-4D21-96B4-438490838815Q77109332-9F55BFD0-5497-4F3E-8051-BDA46E7FCF96
P50
description
researcher ORCID ID = 0000-0003-0044-7921
@en
name
Isabelle Leclerc
@ast
Isabelle Leclerc
@en
Isabelle Leclerc
@es
Isabelle Leclerc
@nl
type
label
Isabelle Leclerc
@ast
Isabelle Leclerc
@en
Isabelle Leclerc
@es
Isabelle Leclerc
@nl
prefLabel
Isabelle Leclerc
@ast
Isabelle Leclerc
@en
Isabelle Leclerc
@es
Isabelle Leclerc
@nl
P108
P108
P21
P31
P496
0000-0003-0044-7921